Alembic Pharmaceuticals Dubai Subsidiary Alvesta Incorporation

Date: 19th October, 2026

Subsidiary Incorporation Disclosure

Alembic Global Holding SA, a Wholly Owned Subsidiary (WOS) of Alembic Pharmaceuticals Limited, has incorporated its own Wholly Owned Subsidiary named Alvesta Pharmaceuticals FZCO in Dubai, United Arab Emirates.

Incorporation Details

• Entity Name: Alvesta Pharmaceuticals FZCO
• Date of Incorporation: 1st September, 2026
• Country of Incorporation: United Arab Emirates
• Date of Intimation Received: 19th October, 2026

Corporate Structure

• Holding Company: Alembic Global Holding SA (AGH)
• Relationship with Listed Entity: Step-Down Wholly Owned Subsidiary
• Industry: Pharmaceuticals

Business Purpose

Alvesta Pharmaceuticals FZCO was incorporated to explore new business opportunities and to promote, sell, and distribute pharmaceutical product(s) of Alembic Pharmaceuticals Limited.

Investment Details

• Consideration Type: Cash consideration
• Cost of Subscription: AED 100,000 (Arab Emirates Dirham One Lakh Only)
• Share Subscription: 100 shares of AED 1,000 each subscribed by Alembic Global Holding SA
• Shareholding Percentage: 100% control through Alembic Global Holding SA

Regulatory Approvals

• Governmental/Regulatory Approvals Required: Not Applicable